The Supreme Court, in a 6-3 decision, ruled that New York's requirement for concealed carry gun permits are too restrictive; the FDA ordered Juul Labs Inc to pull its e-cigarettes from the market; a meningococcal disease outbreak in Florida includes at least 26 total cases and 7 deaths.
In a 6-3 decision, the Supreme Court ruled that the Second Amendment allows citizens in New York to carry a gun outside the home and that states are restricted in what types of gun laws they can enact. The decision, in New York State Rifle & Pistol Association, Inc., et al v Bruen, Superintendent of New York State Police, et al comes as various medical associations have repeatedly declared gun violence to be a public health emergency.
The FDA ordered vaping company Juul Labs to pull its e-cigarettes from the US market. The move follows a nearly 2-year-long review of data from Juul Labs and requests from the company to keep its tobacco and menthol flavored products on the market. Juul’s e-cigarette cartridges with sweet and fruity flavors were barred by the FDA in 2020, and limited marketing for these products began in 2019.
The CDC announced an outbreak of meningococcal disease in Florida, including at least 26 total cases and 7 deaths. A vast majority of these cases and deaths are among gay and bisexual men, and approximately half the cases are among Hispanic men, The New York Times reported. Meningococcal disease is typically spread through close and prolonged contact such as kissing, can manifest as meningitis or septicemia, and can be fatal. While the number of cases are low, epidemiologists are concerned about the outbreak and remind that the disease can affect anyone, not just men who have sex with men. The CDC recommends that people most at risk in the area get vaccinated against meningococcal disease.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Evolving Roles of Antibody-Drug Conjugates in the Treatment of NSCLC
September 7th 2025Antibody-drug conjugates are rapidly reshaping the treatment landscape of non–small cell lung cancer (NSCLC), with advances in design, clinical efficacy, and regulatory approvals tempered by ongoing challenges in toxicity, resistance, and biomarker optimization.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Comparing Global Standards in Lung Cancer: NCCN, ESMO, and CHEST Guidelines
September 6th 2025National Comprehensive Cancer Network (NCCN), the European Society for Medical Oncology (ESMO), and the American College of Chest Physicians (CHEST) offer complementary yet distinct frameworks for lung cancer care, reflecting differences in evidence evaluation, regional adaptation, and policy integration.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More